The Pharma Innovation Journal 

About: The Pharma Innovation Journal is an academic journal. The journal publishes majorly in the area(s): Population & Drug delivery. It has an ISSN identifier of 2277-7694. Over the lifetime, 3478 publications have been published receiving 6773 citations.

A review of the 2019 novel coronavirus (COVID-19) based on current evidence

Abstract: Coronavirus (COVID-19) is an enveloped RNA virus that is diversely found in humans and wild life. A total of six species have been identified to cause disease in humans. They are known to infect the neurological, respiratory, enteric, and hepatic systems. The past few decades have seen endemic outbreaks in the form of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome Related Coronavirus (SARS-CoV). Yet again, we see the emergence of another outbreak due to a new strain called the SARS-CoV-2 virus. The most recent outbreak initially presented as pneumonia of unknown etiology in a cluster of patients in Wuhan, China. The epicenter of infection was linked to seafood and exotic animal wholesale markets in the city. SARS-CoV-2 is highly contagious and has resulted in a rapid pandemic of COVID-19. As the number of cases continues to rise, it is clear that these viruses pose a threat to public health. This review will introduce a general overview of coronavirus and describe the clinical features, evaluation, and treatment of COVID-19 patients. It will also provide a means to raise awareness among primary and secondary healthcare providers during the current pandemic. Furthermore, our review focuses on the most up-to-date clinical information for the effective management, prevention, and counseling of patients worldwide.

The Beck Depression Inventory

Abstract: I. Introduction to the Beck Depression InventoryII. Description of the Test and HistoryIII. Content and Use of the Beck Depression Inventory A. Benefits of the Beck Depression InventoryIV. Psychometric Qualities of Beck Depression InventoryV. Reliability, Validity, and Factor AnalysisVI. Critique of the Beck Depression InventoryVII. Internal Consistency and Test-Retest ReliabilityVIII. Ethical ImplicationsIX. Legal ImplicationsX. Disadvantage (Challenges) of the Beck Depression InventoryXI. Summarization of the Beck Depression InventoryXII. Future Endeavors of the Beck Depression Inventory

Controlled Release Drug Delivery Systems

Abstract: Controlled drug delivery is one which delivers the drug at a predetermined rate, for locally or systemically, for a specified period of time. Continuous oral delivery of drugs at predictable and reproducible kinetics for predetermined period throughout the course of GIT. Controlled release drug delivery employs drug-encapsulating devices from which therapeutic agents may be released at controlled rates for long periods of time, ranging from days to months. Such systems offer numerous advantages over traditional methods of drug delivery, including tailoring of drug release rates, protection of fragile drugs and increased patient comfort and compliance.

Transdermal Drug Delivery System: A Review

Abstract: A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered in this method. A wide variety of pharmaceuticals are now available in transdermal patch form.

Hydrogel: Preparation, Characterization and Applications

Abstract: Hydrogel products constitute three-dimensional networks which contains a group of polymeric materials, the hydrophilic structure of which renders them capable of holding large amounts of water. These biomaterials can integrate large quantum of biological fluids and swell. When swelled, they are soft & rubbery and resemble the living tissue, exhibiting excellent biocompatibility. Broad use of these products in a number of industrial and environmental areas of application is considered to be of prime importance. Today, drug delivery experience several challenges where hydrogel could be one potential answer to those. Due to the vast properties of hydrogel they are widely exposed to different biomedical fields. The primary objective of this article is to concerning classification of hydrogels on different bases, properties of hydrogels and its methods of preparations, physical and chemical characteristics of these products, and technical feasibility of their utilization.